144 related articles for article (PubMed ID: 9204994)
1. Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status.
Filipits M; Suchomel RW; Lechner K; Pirker R
Leukemia; 1997 Jul; 11(7):1073-7. PubMed ID: 9204994
[TBL] [Abstract][Full Text] [Related]
2. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Den Boer ML; Zwaan CM; Pieters R; Kazemier KM; Rottier MM; Flens MJ; Scheper RJ; Veerman AJ
Leukemia; 1997 Jul; 11(7):1078-85. PubMed ID: 9204995
[TBL] [Abstract][Full Text] [Related]
3. MRP expression in acute myeloid leukemia. An update.
Filipits M; Stranzl T; Pohl G; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Adv Exp Med Biol; 1999; 457():141-50. PubMed ID: 10500789
[TBL] [Abstract][Full Text] [Related]
4. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.
Fillpits M; Suchomel RW; Dekan G; Stiglbauer W; Haider K; Depisch D; Pirker R
Br J Cancer; 1997; 75(2):208-12. PubMed ID: 9010028
[TBL] [Abstract][Full Text] [Related]
5. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
7. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
8. MRP and MDR1 gene expression in primary breast carcinomas.
Filipits M; Suchomel RW; Dekan G; Haider K; Valdimarsson G; Depisch D; Pirker R
Clin Cancer Res; 1996 Jul; 2(7):1231-7. PubMed ID: 9816292
[TBL] [Abstract][Full Text] [Related]
9. Expression of the multidrug resistance-associated protein in myelodysplastic syndromes.
Poulain S; Lepelley P; Preudhomme C; Cambier N; Cornillon J; Wattel E; Cosson A; Fenaux P
Br J Haematol; 2000 Sep; 110(3):591-8. PubMed ID: 10997969
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
11. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
[TBL] [Abstract][Full Text] [Related]
12. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract][Full Text] [Related]
14. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M; Turzanski J; Langabeer S; Russell NH
Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
[TBL] [Abstract][Full Text] [Related]
15. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
van der Kolk DM; de Vries EG; Noordhoek L; van den Berg E; van der Pol MA; Müller M; Vellenga E
Leukemia; 2001 Oct; 15(10):1544-53. PubMed ID: 11587212
[TBL] [Abstract][Full Text] [Related]
16. Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts.
Sonneveld P; Wiemer E
Leukemia; 1997 Jul; 11(7):1160-5. PubMed ID: 9205006
[TBL] [Abstract][Full Text] [Related]
17. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia.
Hart SM; Ganeshaguru K; Hoffbrand AV; Prentice HG; Mehta AB
Leukemia; 1994 Dec; 8(12):2163-8. PubMed ID: 7808005
[TBL] [Abstract][Full Text] [Related]
18. New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.
Takeshita A; Shinjo K; Ohnishi K; Ohno R
Jpn J Cancer Res; 1995 Jun; 86(6):607-15. PubMed ID: 7622426
[TBL] [Abstract][Full Text] [Related]
19. Monitoring interactions at ATP-dependent drug efflux pumps.
Hendrikse NH
Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.
Schneider E; Cowan KH; Bader H; Toomey S; Schwartz GN; Karp JE; Burke PJ; Kaufmann SH
Blood; 1995 Jan; 85(1):186-93. PubMed ID: 7528566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]